The 13th Annual Pre-Filled Syringes East Coast Conference will return to Boston in April 2026, continuing as a premier event for the latest innovations in injectable drug delivery.
As part of our leading Drug Delivery Series, the 2026 conference will once again bring together top experts, industry leaders, and innovators for a three-days of key insights and networking. Attendees can expect a comprehensive pre-conference focus day dedicated to advancements in pre-filled syringe design, followed by a dynamic two-day main conference featuring keynote plenaries, interactive panel discussions, and specialized topic streams covering the most pressing industry challenges and breakthrough solutions.
This must-attend event provides invaluable insights for professionals looking to enhance their injectable device portfolios while fostering meaningful connections with key stakeholders across the field. We look forward to welcoming you to Boston in April 2026!
2025 Speakers Included
- Ajit D'Souza, Executive Director, Drug Delivery and Devices, Eli Lilly
- Alan Stevens, Global Head, Complex Devices and Drug Delivery Systems, AbbVie
- Alfredo Ricci, CEO, Althena Medical
- Amardeep Hoonjan, Director Device R&D Lead, Biocompatibility Group, AbbVie
- Andy Pidgeon, Head of Usability, 42 Technology Limited
- Bharat Arora, Director, Global Combination Products Quality, Moderna
- Chris Muenzer, Vice President Innovation and Development, Haselmeier GmbH
- Chuck Ventura, Chief Executive Officer, Ventura Solutions
- Confirmed Senior Representative, Biophorum
- Conor O'Neill, Head of Packaging Development and Design, GSK
- Daniel Davenport, Associate Director Early Engagement and Deviceability, GSK
- Dany Doucet, Director Early Engagement and Deviceability, GSK
- David Vazquez, Head SaMD Legal Manufacturing, Pfizer
- Duncan Paterson, Senior Director, AstraZeneca
- E Guan, Head of Injection Systems, Takeda
- Ellie Younger, Associate Principal Engineer, AstraZeneca
- Fletcher Dix, Sr. Process Characterization and Technology Engineer, Regeneron Pharmaceuticals
- Frances Pencliffe, Consultant Healthcare Devices Engineer, Cambridge Design Partnership
- Greg Moakes, EVP, New Business Development, LTS Device Technologies
- Gretchen Piwinski, Sr Manager Combination Product Development, Regeneron
- Guangli Hu, Director, Merck & Co., Inc.
- James P. Wabby, Global Head, Regulatory Affairs - Emerging Device Technologies and Combination Products, AbbVie
- Jamie Tsung, Director CMC Development, Alnylam Pharmaceuticals
- Jayne Gavrity, Senior Device Engineer, AstraZeneca
- Jerzy Wojcik, Vice President, EdgeOne Medical
- Jia Huang, Associate Director, Merck & Co.
- Joanita Akole Lamien, Sr. Human Factors Engineer, Regeneron Pharmaceuticals
- John Merhige, CEO, Credence MedSystems, Inc.
- Joyce Zhao, Director, Combination Product Development, Takeda Pharmaceuticals
- Julie Li, Sr. Advisor, Eli Lilly
- Kelsey Golk, Biocompatibility Scientist, Pfizer
- Kinsuk Shah, Sr. AD Combination Product Steward, Boehringer Ingelheim
- Kristin Booth, Senior Scientist I, Biocompatibility, AbbVie
- Landon Goldfarb, Biomedical Market Manager, Instron
- Lisa Ray, Executive Director Program Management – Delivery, Device & Connected Solutions, Eli Lilly
- Mark DeStefano, Director, Combination Products and Device R&D, Teva Pharmaceuticals
- Mark Hassett, Vice President of Business Development, Credence MedSystems
- Martin McLoughlin, Head of Device Development, Bristol Myers Squibb
- Masashi Miura, Researcher, Mitsubishi Gas Chemical Company, Inc
- Matt Marber, Senior Usability Engineer, Novo Nordisk
- Max Lerman, Sr. Prin. Consultant / Assoc. Dir. of Technical Learning and Development, Suttons Creek
- Megan Heft, Director, Device Development, AstraZeneca
- Moritz Mond, Product Manager, Gerresheimer
- Naveed Siddiqui, Scientist Formulation, Pfizer Inc.
- Nicholas Mandala, VP Medical Device & Combination Product Technology, Pfizer
- Nolan Dow, Combination Product Development Engineer, Pfizer
- Paul Reyland, Director of Sales, CCL Healthcare
- Ravi Kaushik, Vice President, Patient Integrated Care Innovation Platform, Takeda Pharmaceuticals
- Sarah Fairfield, Associate Director, RA Device and Combination Products Digital Device and Software, AbbVie
- Soumen Das, Medical Device Qualification Lead & Associate Scientific Fellow, Takeda Pharmaceutical Company Limited
- Sriman Banerjee, Head of Packaging Development & CDE, Takeda Pharmaceuticals
- Steve Badelt, Executive Vice President and Managing Partner, Suttons Creek
- Subhi Saadeh, Senior Manager, Combination Products QA, Gilead
- Sujit Basu, Vice President & Head, Pharmaceutical Development, Ionis
- Theresa Scheuble, Head of Design & Innovation, Johnson & Johnson
- Thomas Schwoerer, General Manager, PIA Automation US Inc.
- Tim Quigg, ,Development Director, Crux Product Design Ltd
- Yvette Appleby, Senior Manager Project Management, Pfizer
The full agenda is not yet available for this event.
Follow this event to receive an alert when the agenda becomes available.
Venue
Sheraton Boston Hotel
39 Dalton Street,
Boston, MA, USA
